GGrantIndex
← Leaderboards

Karthik Suresh

Johns Hopkins University

$2,976,640
Attributed
$2,976,640
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $568.6K · FY201425
$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,976,640 · 3

By mechanism

R01$2,032,313 · 1
K08$828,000 · 1
F32$116,327 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Fatty Acids

Research focus

Fatty AcidsPathway InteractionsVanilloidCalciumReactive Oxygen SpeciesEndothelial CellsReceptorRegulationLinkLungIn VivoFunctional DisorderEndotheliumNovel TherapeuticsCell PhysiologyMitochondrial DysfunctionPhenotypeInsightHypoxiaIn VitroMigrationExhibitsBlood VesselsDistal

Grant awards (12)

Metabolic regulation of Ca2+ entry and endothelial-mesenchymal transition in pulmonary arterial hypertension$409,375
R01 · FY2025 · HL · contact PI
Metabolic regulation of Ca2+ entry and endothelial-mesenchymal transition in pulmonary arterial hypertension$401,188
R01 · FY2024 · HL · contact PI
Metabolic regulation of Ca2+ entry and endothelial-mesenchymal transition in pulmonary arterial hypertension$409,375
R01 · FY2023 · HL · contact PI
Metabolic regulation of Ca2+ entry and endothelial-mesenchymal transition in pulmonary arterial hypertension$409,375
R01 · FY2022 · HL · contact PI
Metabolic regulation of Ca2+ entry and endothelial-mesenchymal transition in pulmonary arterial hypertension$403,000
R01 · FY2021 · HL · contact PI
ROS-induced endothelial dysfunction in pulmonary arterial hypertension$165,600
K08 · FY2021 · HL · contact PI
ROS-induced endothelial dysfunction in pulmonary arterial hypertension$165,600
K08 · FY2020 · HL · contact PI
ROS-induced endothelial dysfunction in pulmonary arterial hypertension$165,600
K08 · FY2019 · HL · contact PI
ROS-induced endothelial dysfunction in pulmonary arterial hypertension$165,600
K08 · FY2018 · HL · contact PI
ROS-induced endothelial dysfunction in pulmonary arterial hypertension$165,600
K08 · FY2017 · HL · contact PI
Role of CD36 in ROS induced Ca influx in lung microvascular endothelial cells$55,329
F32 · FY2015 · HL · contact PI
Role of CD36 in ROS induced Ca influx in lung microvascular endothelial cells$60,998
F32 · FY2014 · HL · contact PI